Trial start —: Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay source ↗
Trial start —: The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research source ↗
Trial start —: Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx IGH Assay source ↗
Trial start —: The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/ source ↗
Upcoming milestones
Mar 30, 2027 (ESTIMATED) · · The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research · NCT06222164
Estimated primary completion per ClinicalTrials.gov. Dates move.
The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.